ZH
RU
ES

Deuterated drugs listed

Deuterated drugs listed, Total:25 items.

In the international standard classification, Deuterated drugs listed involves: Buildings, Pharmaceutics, Medical sciences and health care facilities in general, Test conditions and procedures in general, HEALTH CARE TECHNOLOGY.

US-CFR-file, Deuterated drugs listed

• CFR 21-822.15-2013 Food and Drugs. Part822:Postmarket surveillance. Section822.15:How long must I conduct postmarket surveillance of my device?
• CFR 21-822.7-2013 Food and Drugs. Part822:Postmarket surveillance. Section822.7:What should I do if I do not agree that postmarket surveillance is appropriate?
• CFR 21-814.3-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.3:Definitions.
• CFR 21-814.84-2013 Food and Drugs. Part814:Premarket approval of medical devices. Section814.84:Reports.
• CFR 21-814.20-2013 Food and Drugs. Part814:Premarket approval of medical devices. Section814.20:Application.
• CFR 21-814.39-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.39:PMA supplements.
• CFR 21-73.530-2013 Food and Drugs. Part73:Listing of color additives exempt from certification. Section73.530:Spirulina extract.
• CFR 21-814.100-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.100:Purpose and scope.
• CFR 21-814.116-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.116:Procedures for review of an HDE.
• CFR 21-814.44-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.44:Procedures for review of a PMA.
• CFR 21-814.104-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.104:Original applications.
• CFR 21-822.3-2013 Food and Drugs. Part822:Postmarket surveillance. Section822.3:How do you define the terms used in this part?
• CFR 21-822.9-2013 Food and Drugs. Part822:Postmarket surveillance. Section822.9:What must I include in my submission?
• CFR 21-814.37-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.37:PMA amendments and resubmitted PMAs.
• CFR 21-73.350-2013 Food and Drugs. Part73:Listing of color additives exempt from certification. Section73.350:Mica-based pearlescent pigments.
• CFR 21-73.3106-2013 Food and Drugs. Part73:Listing of color additives exempt from certification. Section73.3106:1,4-Bis[4-(2- methacryloxyethyl) phenylamino]anthraquinone co-polymers.
• CFR 21-73.3100-2013 Food and Drugs. Part73:Listing of color additives exempt from certification. Section73.3100:1,4-Bis[(2-hydroxyethyl)amino]-9,10-anthracenedione bis(2-methyl-2-propenoic)ester co-polymers.

Group Standards of the People's Republic of China, Deuterated drugs listed

• T/SZCC 001-2023 Shenzhen biomedicine Industry "industrial upstairs"Design guidelines
• T/CNPPA 3019-2022 Guidance of equivalence/replaceability assessment and compatibility studies for postapproval changes to pharmaceutical packages

RU-GOST R, Deuterated drugs listed

• GOST R 56701-2015 Medicines for medical applications. Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals

US-FCR, Deuterated drugs listed

• FCR 21 CFR PART 99-2015 DISSEMINATION OF INFORMATION ON UNAPPROVED/ NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES
• FCR 21 CFR PART 99-2013 DISSEMINATION OF INFORMATION ON UNAPPROVED/ NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES

IX-EU/EC, Deuterated drugs listed

• 87/22/EEC-1986 Council Directive on the Approximation of National Measures Relating to the Placing on the Market of High- Technology Medicinal Products, Particularly Those Derived from Biotechnology
• 93/41/EEC-1993 Council Directive Repealing Directive 87/22/EEC on the Approximation of National Measures Relating to the Placing on the Market of High- Technology Medicinal Products, Particularly Those Derived from Biotechnology
• 2008/31/EC-2008 DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Directive 98/8/EC concerning the placing of biocidal products on the market, as regards the implementing powers conferred on the Commission

Others:   What is the deuteration rate of deuterated drugs, Deuterated drugs listed, Deuterated drugs approved for marketing, Deuterated drugs listed, Deuterated drugs already on the market, Which drugs contain deuterium, Deuterated listed products, Approved deuterated drugs.